Elevated expression of CKS1B at 1q21 is highly correlated with short survival in myeloma.

被引：1
|
作者：
Zhan, FH
Sawyer, J
Gupta, S
Huang, YS
Anaissie, E
Xu, HW
Hanamura, I
Santra, M
Zangari, M
Lee, CK
Fassas, A
van Rhee, F
Hollmig, K
Talamo, G
Thertulian, R
Tricot, G
Barlow, W
Rasmussen, E
Crowley, J
Barlogie, B
John, S
机构：
[1] Univ Arkansas Med Sci, Myeloma Inst Res & Therapy, Little Rock, AR 72205 USA
[2] Canc Res & Biostat, Seattle, WA USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.77.77
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
77
引用
收藏
页码：26A / 26A
页数：1
相关论文
共 50 条
  • [21] CKS1B Nuclear Expression Predicts an Adverse Outcome for Multiple Myeloma Patients Treated with Bortezomib.
    Chen, M-H
    Qi, C.
    Chang, H.
    MODERN PATHOLOGY, 2011, 24 : 290A - 290A
  • [22] Amp 1q21 is more predictable with dismal survival than gain 1q21 of newly diagnosed multiple myeloma in real-world analysis
    Wang, Yu-Tong
    Bao, Li
    Chu, Bin
    Chen, Xiao-Huan
    Lu, Min-Qiu
    Shi, Lei
    Gao, Shan
    Fang, Li-Juan
    Xiang, Qiu-Qing
    Ding, Yue-Hua
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2022, 36 (07)
  • [23] Amplification of 1q21 is associated with poor outcome after treatment with bortezomib in relapsed/refractory multiple myeloma.
    Drach, Johannes
    Sagaster, Verena
    Odelga, Victoria
    Kaufmann, Hannes
    Ackermann, Jutta
    Galhuber, Markus
    Zojer, Niklas
    Kueenburg, Elisabeth
    Zielinski, Christoph
    Wieser, Rotraud
    Ludwig, Heinz
    BLOOD, 2006, 108 (11) : 970A - 971A
  • [24] Prognostic value of 1q21 amplification in multiple myeloma
    Abramova, T. V.
    Obukhova, T. N.
    Mendeleev, L. P.
    Pokrovskaya, O. S.
    Gribanova, E. O.
    Ryzhko, V. V.
    Grebenyuk, L. A.
    Nareyko, M. V.
    Solovyev, M. V.
    Votyakova, O. M.
    Kulikov, S. M.
    Rusinov, M. A.
    Savchenko, V. G.
    TERAPEVTICHESKII ARKHIV, 2017, 89 (07) : 32 - +
  • [25] The Role of 1q21 Gain on the Prognosis of Multiple Myeloma
    Dong Hui Xing
    Jin Huan Wang
    Zhi Gang Zhao
    JournalofNutritionalOncology, 2021, 6 (02) : 50 - 56
  • [26] Prognostic Value of 1q21 Gain in Multiple Myeloma
    Chen, Dangui
    Zhou, Di
    Xu, Jingyan
    Zhou, Rongfu
    Ouyang, Jian
    Chen, Bing
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (03): : E159 - E164
  • [27] CKS1B expression and genetic analysis in cutaneous squamous cell carcinoma
    Salgado, R.
    Toll, A.
    Alameda, F.
    Martin-Ezquerra, G.
    Martorell, A.
    Baro, T.
    Salido, M.
    Almenar, S.
    Barranco, C.
    Sanmartin, O.
    Pujol, R.
    Sole, F.
    Espinet, B.
    CHROMOSOME RESEARCH, 2009, 17 : 142 - 143
  • [28] EXPRESSION OF MCL1, GSTP1, AND CKS1B GENES IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE AND MULTIPLE MYELOMA
    Stella, F.
    Fantl, D.
    Arbelbide, J.
    Schutz, N.
    Slavutsky, I.
    HAEMATOLOGICA, 2012, 97 : 335 - 335
  • [29] CKS1B gene amplification is a frequent event and associated with tumor progression in multiple myeloma
    Qi, C
    Reece, D
    Reader, JC
    Ning, Y
    Chang, H
    MODERN PATHOLOGY, 2006, 19 : 242A - 242A
  • [30] CKS1B gene amplification is a frequent event and associated with tumor progression in multiple myeloma
    Qi, C
    Reece, D
    Reader, JC
    Ning, Y
    Chang, H
    LABORATORY INVESTIGATION, 2006, 86 : 242A - 242A
12345